Successful completion of the ID-ALS study Part 1: genetic testing of 1.000 people with ALS in Germany

The first part of the ID-ALS study to identify genetic alterations in people with amyotrophic lateral sclerosis (ALS) was successfully completed by Ambulanzpartner on 30.10.2022. In the study